| Literature DB >> 32150007 |
Julie Copelyn1,2, Jeffrey R Hincks3, Jo M Wilmshurst4, Wonita Petersen5, Wayne Howard6, Sabelle Jallow6, Shelina Moonsamy6, Lerato Seakamela6, Melinda Suchard6,7, Marc S Collett3, Brian Eley1,2.
Abstract
Pocapavir exhibits antiviral activity against both polio and nonpolio enteroviruses. There is limited experience of the use of this investigational drug in young children with enteroviral infection. We describe the successful clearance of prolonged immunodeficiency-associated vaccine-derived type 3 poliovirus infection by pocapavir in an infant with underlying X-linked agammaglobulinemia.Entities:
Mesh：
Substances：
Year: 2020 PMID： 32150007 DOI： 10.1097/INF.0000000000002584
Source DB: PubMed Journal: Pediatr Infect Dis J ISSN： 0891-3668 Impact factor: 2.129